Cargando…
Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring
BACKGROUND: Concern for drug-drug interactions leading to treatment failure and drug-resistant strains have discouraged clinicians from attempting concomitant treatment of hepatitis C virus (HCV) and tuberculosis (TB). Increased metabolism of direct-acting antivirals (DAAs) by rifamycins has hindere...
Autores principales: | Ashkin, Alex, Alexis, Afe, Ninneman, Megan, Tresgallo, Rene Rico, Ashkin, David, Peloquin, Charles A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296065/ https://www.ncbi.nlm.nih.gov/pubmed/37383253 http://dx.doi.org/10.1093/ofid/ofad237 |
Ejemplares similares
-
Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014
por: Heysell, Scott K., et al.
Publicado: (2015) -
2354. Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for rifampin-resistant or treatment-intolerant TB disease
por: Haley, Connie A, et al.
Publicado: (2022) -
Prevalence of Intestinal Helminth Coinfection in Drug-Resistant Tuberculosis in Uganda
por: Baluku, Joseph Baruch, et al.
Publicado: (2022) -
The Challenges of Diagnosing Tuberculous Meningitis and Importance of Early Intervention
por: Ashkin, Alex, et al.
Publicado: (2023) -
Optical Trapping and Manipulation of Neutral Particles Using Lasers: a Reprint Volume with Commentaires
por: Ashkin, Arthur
Publicado: (2006)